Skip to main content
Top
Published in: Indian Journal of Gastroenterology 5/2018

01-09-2018 | IMAGE

A rare case of disseminated histoplasmosis in a patient with Crohn’s disease on immunosuppressive treatment

Authors: Bhavesh Bhut, Akshay Kulkarni, Varnika Rai, Vinita Agrawal, Abhai Verma, Manoj Jain, Rungmei S K Marak, Ajai Kumar Dixit, Uday C Ghoshal

Published in: Indian Journal of Gastroenterology | Issue 5/2018

Login to get access

Excerpt

A 45-year-old male presented in December 2017 with fever, bloody diarrhea, weight loss, fatigue, watery peri-anal discharge, and left lower abdominal colicky pain of 4-month duration. He underwent left hemicolectomy followed by a 9-month anti-tubercular drug treatment with isoniazid, rifampicin, ethambutol, and pyrazinamide for subacute intestinal obstruction and descending colon stricture 4 years back. The resected specimen revealed transmural lymphocytic infiltration and non-caseating granuloma without acid-fast bacilli. Though he remained well for the next 3 years, he experienced recurrent symptoms. A colonoscopy at another hospital at this stage revealed multiple rectosigmoid and colonic ulcers leading to partial stricture (which was also substantiated by a colonoscopy at our hospital later, Fig. 1a) and biopsy revealed moderate mononuclear inflammatory infiltrate in the lamina propria and dilated blood vessels (Fig. 1b). Zeil-Neelson stain was negative for the acid-fast bacilli. Oral prednisolone (50 mg/day) and azathioprine (100 mg/day) were started for a possible diagnosis of Crohn’s disease (CD). After a month, the patient presented with proximal myopathy, bleeding per rectum, and peri-anal ulceration (Fig. 1c), fever, and cervical lymphadenopathy (Fig. 1d). A fine needle aspiration and biopsy of the cervical lymph node revealed histoplasmosis (Fig. 2a–c). Peri-anal ulcer biopsy also revealed histoplasmosis (Fig. 2d). Colonoscopy revealed rectosigmoid ulceration with stricture (Fig. 1a) and biopsy also revealed histoplasmosis (Fig. 3a). Serological test for human immunodeficiency virus (HIV) infection was negative. A computerized tomographic scan showed bilateral adrenal enlargement (Fig. 3b), and thickening of the ileocecal junction (Fig. 3c). With a diagnosis of disseminated histoplasmosis in a patient with CD on immunosuppressive treatment, prednisolone and azathioprine were withheld, treatment with liposomal amphotericin B started, and continued for the next 21 days; his fever subsided, lymph node regressed, peri-anal ulcer showed healthy granulation tissue. At this stage, itraconazole was started. However, he left the hospital due to financial constraint.
Literature
1.
go back to reference Kishore J, Ghoshal U, Ghoshal UC, et al. Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol. 2004;53:1155–60.CrossRef Kishore J, Ghoshal U, Ghoshal UC, et al. Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol. 2004;53:1155–60.CrossRef
2.
go back to reference Park DI, Hisamatsu T, Chen M, et al. Asian Organization for Crohn’s and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management. Intest Res. 2018;16:17–25.CrossRef Park DI, Hisamatsu T, Chen M, et al. Asian Organization for Crohn’s and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management. Intest Res. 2018;16:17–25.CrossRef
3.
go back to reference Inflammatory Bowel Disease Group. Chinese Society of Gastroenterology, Chinese Medical Association. Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication). Intest Res. 2018;16:178–93.CrossRef Inflammatory Bowel Disease Group. Chinese Society of Gastroenterology, Chinese Medical Association. Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication). Intest Res. 2018;16:178–93.CrossRef
4.
go back to reference Dotson JL, Crandall W, Mousa H, et al. Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: a case series. Inflamm Bowel Dis. 2011;17:56–61.CrossRef Dotson JL, Crandall W, Mousa H, et al. Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: a case series. Inflamm Bowel Dis. 2011;17:56–61.CrossRef
5.
go back to reference Kauffman CA. Histoplasmosis: clinical and laboratory update. Clin Microbiol Rev. 2007;20:115–32.CrossRef Kauffman CA. Histoplasmosis: clinical and laboratory update. Clin Microbiol Rev. 2007;20:115–32.CrossRef
Metadata
Title
A rare case of disseminated histoplasmosis in a patient with Crohn’s disease on immunosuppressive treatment
Authors
Bhavesh Bhut
Akshay Kulkarni
Varnika Rai
Vinita Agrawal
Abhai Verma
Manoj Jain
Rungmei S K Marak
Ajai Kumar Dixit
Uday C Ghoshal
Publication date
01-09-2018
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 5/2018
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-018-0886-1

Other articles of this Issue 5/2018

Indian Journal of Gastroenterology 5/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.